Tilray Brands, Inc. Common Stock TLRY

GlobeNewswire Inc. 12 nov

Tilray Brands' three Oregon craft beer subsidiaries—10 Barrel Brewing, Widmer Brothers Brewing, and Hop Valley Brewing—have been named Official Craft Beer Partners of the Portland Trail Blazers. 10 Barrel also becomes the team's first Official Canned Cocktail Partner. The partnership expands craft beverage offerings at Moda Center through new venues like Schonely's Oregon Beer Hall and extends to the Rip City Bar Network.

Zacks Investment Research 11 nov

Green Thumb Industries (GTBIF) reported Q3 2026 sales growth of 11.3% to $324.4 million but missed earnings estimates with a 2-cent loss per share. While retail and CPG revenues grew 10% and 16% respectively, the company faces ongoing pricing pressure and increased competition. Management expects flat to slightly lower Q4 revenues and continued price compression, though the company maintains financial strength with $316 million in cash and continues shareholder buybacks. Analysts recommend a wait-and-watch approach given industry headwinds.

The Motley Fool 10 nov

The U.S. government's reclassification of medical cannabis from Schedule I to Schedule III primarily benefits U.S.-based cannabis operators through lower tax bills, not Canadian producer Tilray. While rescheduling may be a step toward legalization, it doesn't guarantee future reform and could take years to materialize. Investors should be cautious about overreacting to rescheduling news, as Tilray's stock has historically surged temporarily on cannabis reform announcements only to decline to new lows.

The Motley Fool 9 nov

Tilray announced a consolidation of its Canadian operations expected to generate $10 million in annual cost savings, leading to slightly raised adjusted EBITDA guidance for fiscal 2027 ($70-75 million vs. previous $68-75 million). However, the company continues to burn cash and faces challenges in the competitive Canadian cannabis market with low margins. Analysts remain cautious, suggesting investors take a wait-and-see approach as the improvements are insufficient to make the stock a compelling buy.

The Motley Fool 8 nov

An analysis of five major cannabis stocks reveals significant differences in financial health. Cronos Group leads with approximately $841 million in cash and no significant debt, followed closely by SNDL, which is debt-free with positive free cash flow. Tilray and Canopy Growth continue to struggle with debt and negative cash flow despite some revenue growth, while Aurora Cannabis has a smaller liquidity cushion. A strong balance sheet provides financial flexibility but doesn't guarantee profitability or shareholder returns.